A Clinical Study of Uterine Sarcoma.
- Author:
Seung Hyun LIM
;
Hee Won SONG
;
Tae Gun IM
;
Chul UM
;
Kwan Sik KIM
;
Byung Chan OH
- Publication Type:Original Article
- Keywords:
Uterine Sarcoma;
Leiomyosarcoma
- MeSH:
Brain;
Chemotherapy, Adjuvant;
Drug Therapy;
Female;
Follow-Up Studies;
Gynecology;
Humans;
Jeollabuk-do;
Leiomyosarcoma;
Lung;
Menorrhagia;
Neoplasm Metastasis;
Obstetrics;
Prognosis;
Radiotherapy;
Retrospective Studies;
Sarcoma*;
Survival Rate;
Uterine Hemorrhage
- From:Korean Journal of Obstetrics and Gynecology
2000;43(7):1223-1227
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: Uterine sarcomas are rare and characterized by rapid clinical progression and poor prognosis. The manegement of uterine sarcoma has been challenged. The purpose of this study was to investigate the clinicopathologic findings and outcome of patients with uterine sarcoma METHODS: From Sep. 1990 to July. 1999, 8 patients with histologically proven uterine sarcoma at department of obstetrics and gynecology of Chonbuk University Hospital were evaluated for their clinical profiles and survival retrospectively RESULTS: The age of patients with uterine sarcoma ranged 31 to 60, and the mean age was 46 years. The most common pathologic type of uterine sarcoma was leiomyosarcoma. The common presenting symptom were irregular uterine bleeding, hypermenorrhea and lower abdominal palpable mass. The patients with uterine sarcoma were treated by surgery, post-operative radiotherapy and adjuvant chemotherapy. The mean follow up duration was 34.1 months. The 2 year survival rate was 50%. Distant metastasis were reveled at two patients, and the sites are lung and brain. CONCLUSIONS: Uterine sarcomas are aggressive tumor with a poor prognosis. The Major treatment is surgery and the effect of chemotherapy and radiotherapy were undetermined.
